<DOC>
	<DOC>NCT02343250</DOC>
	<brief_summary>A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Cilnidipine</mesh_term>
	<criteria>Age between 20 and 40 Signed informed consent Has a history of hypersensitivity to IP ingredients Hypertension of hypotension</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>